An application made for this job — a tailored resume and cover letter that speak straight to the posting.
UT Southwestern Medical Center seeks a Computational Research Scientist to lead machine-learning efforts identifying novel therapeutic targets and guiding the engineering of next-generation immunotherapies for cancer. You will build models integrating multi-omic data and work with experimental colleagues to translate findings to the clinic.
The role is senior, high autonomy, with responsibility to set scientific direction, mentor staff, and publish results while collaborating across UT
The laboratory of Dr. Jaehyuk Choi, M.D., Ph.D., Director of the Center for Cellular Therapies and Cancer Immunology in the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern is seeking a Computational Research Scientist to lead machine-learning efforts that identify novel therapeutic targets and guide the engineering of next-generation immunotherapies for cancer.
The Center for Cellular Therapies and Cancer Immunology in the Harold C. Simmons Comprehensive Cancer Center is looking to hire a Computational Research Scientist at the interface of machine learning, cancer genomics, and immunology. You will build and apply computational methods that turn large-scale multi-omic and functional datasets into validated therapeutic hypotheses, while working side by side with experimental and translational scientists to bring those hypotheses to the clinic.
This is a senior, high-autonomy position suited to someone who wants their models to drive biological discovery to therapies. You will help set scientific direction, mentor junior computational and experimental scientists, and serve as the analytical backbone of a program developing novel immunotherapies within a new center.
Depending on your interests and strengths, your work can center on identifying novel cancer immunotherapy targets and/or developing novel therapeutics. Approaches may include:
The Choi Laboratory is led by Jaehyuk Choi, M.D., Ph.D., Director of the Center for Cellular Therapies and Cancer Immunology and Professor in the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern (with an appointment in Dermatology). As director of a newly formed center within an NCI-designated comprehensive cancer center, Dr. Choi leads a growing, well-resourced program at the intersection of cancer genomics, immunology, and cell therapy, and is actively building the team to match that ambition.
The lab’s research falls into two complementary thrusts, precision medicine and immune engineering, both aimed at understanding the genetic basis of cancer and turning that understanding into new therapies. Findings have been published in Nature, Nature Cancer, Blood, and other leading journals.
The heart of the lab’s work: using genomics and computation to define the molecular bases of cancer, with a deep focus on T-cell malignancies, and to translate those insights directly into the clinic. The lab has identified the driver mutations and recurrent, targetable alterations that shape these diseases (for example, alterations in the JAK/STAT pathway), and has built clinical–molecular correlations that connect a tumor’s genotype to its biology and its response to therapy. This is the program’s established core, with a track record of moving molecular discoveries toward precision treatment of cancers that have lacked effective options.
Building on that foundation, the lab engineers next-generation immunotherapies, for instance, harnessing naturally occurring mutations from human T-cell cancers to make engineered T cells more potent and persistent, and applying computational protein design to create novel therapeutic molecules and cell therapies.
experience with deep learning for genomics or protein/sequence design, neoantigen or TCR analysis, CRISPR or other functional-screen analysis, or engineered cell-therapy programs.